O. Acosta, E. Mylona, L. Dain, M. Voisin, C. Lizee et al., Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy, Radiother. Oncol, vol.125, pp.492-499, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01671693

E. Mylona, O. Acosta, T. Lizee, C. Lafond, G. Crehange et al., Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy, Int J Radiat Oncol Biol Phys, vol.104, issue.2, pp.343-54, 2019.

A. Largent, A. Barateau, J. C. Nunes, E. Mylona, J. Castelli et al., Comparison of deep learning-based and patch-based methods for pseudo-CT generation in MRI-based prostate dose planning, Int J Radiat Oncol, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02304378

E. Mylona, A. Cicchetti, T. Rancati, F. Palorini, C. Fiorino et al., Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy : assessment of cohort and method effects, Radiother. Oncol
URL : https://hal.archives-ouvertes.fr/hal-02532850

E. Mylona, C. Lebreton, C. Fontaine, G. Crehange, N. Magné et al., Comparison of machine learning algorithms and oversampling techniques for urinary toxicity prediction after prostate cancer radiotherapy, IEEE proceedings, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02472484

T. ?-lizee, E. Mylona, C. Lafond, S. Supiot, O. Acosta et al., Analysis of the urethro-vesical region for urinary toxicity prediction after prostate radiotherapy, ESTRO as poster, vol.127, pp.432-433, 2018.

E. Mylona, O. Acosta, T. Lizee, C. Lafond, G. Crehange et al., Bladder and urethra subregions predicting urinary toxicity after prostate cancer radiotherapy, ESTRO as poster, vol.133, p.449, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02177163

E. Mylona, A. Cicchetti, T. Rancati, F. Palorini, S. Supiot et al., Predicting urinary toxicity via 2D and 3D dose map analyses in prostate cancer radiotherapy, Radiother. Oncol, vol.133, p.326, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02177166

O. Acosta, C. Lafond, A. Barateau, B. Houede, A. Largent et al., Improved prostate cancer radiotherapy planning with decreased dose in a rectal subregion highly predictive for toxicity, 2019.

T. ?-lizée, O. Acosta, E. Mylona, L. Dain, M. Lafond et al., Développement d'une méthode de segmentation automatique de l'urètre sur tomodensitométrie de planification permettant d'évaluer la dose urétrale en cas de radiothérapie prostatique, Cancer/Radiothérapie, vol.21, p.706, 2017.

O. Acosta, E. Mylona, C. Lafond, G. Créhange, S. Supiot et al., International Mobilities ? Project: Spatial characterization of urinary toxicity using dose-surface maps. Responsible: Tiziana Rancati, Place: Fondazione IRCCS Istituto Nazionale dei Tumori, Cancer/Radiothérapie, vol.23, pp.9-23, 2018.

?. Project, Responsible: Martin Ebert, Place: Sir Charles Gairdner Hospital, Grant: PHC FASIC mobility grant & UBL mobility grant, 2018.

P. Rawla, Epidemiology of Prostate Cancer, World J Oncol, vol.10, pp.63-89, 2019.

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, vol.68, pp.394-424, 2018.

A. Stangelberger, M. Waldert, and B. Djavan, Prostate cancer in elderly men, Rev Urol, vol.10, pp.111-120, 2008.

A. Heidenreich, G. Aus, M. Bolla, S. Joniau, V. B. Matveev et al., EAU Guidelines on Prostate Cancer, Eur Urol, vol.53, pp.68-80, 2008.

A. Heidenreich, P. J. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update, Eur Urol, vol.65, pp.124-161, 2013.

. Varenhorst-e, . Berglund-k, O. Löfman, and . Pedersen-k, Inter-observer Variation in Assessment of the Prostate by Digital Rectal Examination, Br J Urol, vol.72, pp.173-179, 1993.

D. P. Ankerst and I. M. Thompson, Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification. Arch Ital Di Urol Androl Organo Uff, Di] Soc Ital Di Ecogr Urol e Nefrol, vol.78, pp.125-134, 2006.

U. Stenman, P. Abrahamsson, G. Aus, H. Lilja, C. Bangma et al., Prognostic value of serum markers for prostate cancer, Scand J Urol Nephrol, vol.39, pp.64-81, 2005.

L. H. Sobin, M. Gospodarowicz, K. Mary, and C. Wittekind, International Union against Cancer. TNM classification of malignant tumours, 2009.

A. V. D'amico, R. Whittington, S. B. Malkowicz, D. Schultz, K. Blank et al., Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer, JAMA, vol.280, p.969, 1998.

T. J. Wallace, T. Torre, M. Grob, J. Yu, I. Avital et al., Current approaches, challenges and future directions for monitoring treatment response in prostate cancer, J Cancer, vol.5, pp.3-24, 2014.

C. J. Welty, M. R. Cooperberg, and P. R. Carroll, Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer, Curr Opin Urol, vol.24, pp.288-92, 2014.

J. Adolfsson, Watchful waiting and active surveillance: the current position, BJU Int, vol.102, pp.10-14, 2008.

G. Haar, . Ter, and C. Coussios, High intensity focused ultrasound: physical principles and devices, Int J Hyperthermia, vol.23, pp.89-104, 2007.

L. Poissonnier, F. Murat, A. Belot, R. Bouvier, M. Rabilloud et al., Locally recurrent prostatic adenocarcinoma after exclusive radiotherapy: results of high intensity focused ultrasound, Prog Urol, vol.18, pp.223-232, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00395713

H. E. Barker, J. Paget, A. A. Khan, and K. J. Harrington, The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence, Nat Rev Cancer, vol.15, pp.409-434, 2015.

H. E. Romeijn, R. K. Ahuja, J. F. Dempsey, and A. Kumar, A column generation approach to radiation therapy treatment planning using aperture modulation, SIAM J Optim, 2005.

T. Bortfeld, IMRT: a review and preview, Phys Med Biol, vol.51, pp.363-79, 2006.

B. Cho, Intensity-modulated radiation therapy: a review with a physics perspective, Radiat Oncol J, vol.36, pp.1-10, 2018.

N. G. Zaorsky, S. W. Keith, T. Shaikh, P. L. Nguyen, E. M. Horwitz et al., Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities, Am J Clin Oncol, vol.41, pp.409-424, 2018.

D. P. Dearnaley, G. Jovic, I. Syndikus, V. Khoo, R. A. Cowan et al., Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, Lancet Oncol, vol.15, pp.464-73, 2014.

K. Cheung, Intensity modulated radiotherapy: advantages, limitations and future developments, Biomed Imaging Interv J, vol.2, p.19, 2006.

B. W. Fischer-valuck, Y. J. Rao, and J. M. Michalski, Intensity-modulated radiotherapy for prostate cancer, Transl Androl Urol, vol.7, pp.297-307, 2018.

W. Schlegel, New Technologies in 3D Conformal Radiation Therapy: Introduction and Overview, New Technol. Radiat. Oncol, pp.1-6, 2006.

J. Sonke, M. Aznar, and C. Rasch, Adaptive Radiotherapy for Anatomical Changes, Semin Radiat Oncol, vol.29, pp.245-57, 2019.

H. Alasti, M. P. Petric, C. N. Catton, and P. R. Warde, Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate, Int J Radiat Oncol Biol Phys, 2001.

D. J. Moseley, E. A. White, K. L. Wiltshire, T. Rosewall, M. B. Sharpe et al., Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate, Int J Radiat Oncol Biol Phys, vol.67, pp.942-53, 2007.

A. Dang, P. A. Kupelian, M. Cao, N. Agazaryan, and A. U. Kishan, Image-guided radiotherapy for prostate cancer, Transl Androl Urol, vol.7, pp.308-328, 2018.

E. Pang, K. Knight, Q. Fan, S. Tan, K. W. Ang et al., Analysis of intra-fraction prostate motion and derivation of duration-dependent margins for radiotherapy using real-time 4D ultrasound, Phys Imaging Radiat Oncol, vol.5, pp.102-109, 2018.

D. Nguyen, Q. Lyu, D. Ruan, D. O'connor, D. A. Low et al., A comprehensive formulation for volumetric modulated arc therapy planning, Med Phys, vol.43, pp.4263-72, 2016.

C. R. King, J. Lehmann, J. R. Adler, and J. Hai, CyberKnife Radiotherapy for Localized Prostate Cancer: Rationale and Technical Feasibility, Technol Cancer Res Treat, vol.2, pp.25-34, 2003.

K. Mittauer, B. Paliwal, P. Hill, J. E. Bayouth, M. W. Geurts et al., A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies, Cureus, vol.10, 2018.

D. H. Moon, J. A. Efstathiou, and R. C. Chen, What is the best way to radiate the prostate in 2016?, Urol Oncol Semin Orig Investig, vol.2016, pp.1-10

V. Beckendorf, S. Guerif, L. Prisé, E. Cosset, J. Bougnoux et al., 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial, Int J Radiat Oncol, vol.80, pp.1056-63, 2011.

J. M. Michalski, J. Moughan, J. Purdy, W. Bosch, D. W. Bruner et al., Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial, JAMA Oncol, vol.4, p.180039, 2018.

D. A. Kuban, S. L. Tucker, L. Dong, G. Starkschall, E. H. Huang et al., Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer, Int J Radiat Oncol Biol Phys, vol.70, pp.67-74, 2008.

S. Peeters, W. D. Heemsbergen, P. Koper, W. Van-putten, A. Slot et al., Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy, J Clin Oncol, vol.24, pp.1990-1996, 2006.

M. J. Zelefsky, Z. Fuks, M. Hunt, H. J. Lee, D. Lombardi et al., High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer, J Urol, vol.166, pp.876-81, 2001.

A. L. Zietman, M. L. Desilvio, J. D. Slater, C. J. Rossi, D. W. Miller et al., Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate, JAMA, vol.294, p.1233, 2005.

R. Cheung, S. L. Tucker, A. K. Lee, R. De-crevoisier, L. Dong et al., Dose-response characteristics of low-and intermediate-risk prostate cancer treated with external beam radiotherapy, Int J Radiat Oncol, vol.61, pp.993-1002, 2005.

R. Cheung, S. L. Tucker, L. Dong, and D. Kuban, Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy, Int J Radiat Oncol Biol Phys, vol.56, pp.1234-1274, 2003.

A. L. Zietman, K. Bae, J. D. Slater, W. U. Shipley, J. A. Efstathiou et al., Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09, J Clin Oncol, vol.28, pp.1106-1117, 2010.

W. D. Heemsbergen, A. Al-mamgani, A. Slot, M. Dielwart, and J. Lebesque, Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival, Radiother Oncol, vol.110, pp.104-113, 2014.

C. R. Dulaney, D. O. Osula, E. S. Yang, and S. Rais-bahrami, Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine, Prostate Cancer, p.4897515, 2016.

C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti, Dose-volume effects for normal tissues in external radiotherapy: Pelvis, Radiother Oncol, vol.93, pp.153-67, 2009.

C. M. and R. V. , Pelvic Irradiation and Its Effects on the Lower Urinary Tract: a Literature Review, Curr Bladder Dysfunct Rep, vol.10, pp.295-302, 2015.

A. Leplège and S. Hunt, The Problem of Quality of Life in Medicine, JAMA J Am Med Assoc, vol.278, p.47, 1997.

F. J. Berkey, Managing the adverse effects of radiation therapy, Am Fam Physician, 2010.

M. S. Litwin, D. P. Lubeck, J. M. Henning, and P. R. Carroll, Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the capsure database, J Urol, pp.63222-63223, 1998.

J. A. Clark, T. S. Inui, R. A. Silliman, B. G. Bokhour, S. H. Krasnow et al., Patients' perceptions of quality of life after treatment for early prostate cancer, J Clin Oncol, 2003.

D. T. Eton and S. J. Lepore, Prostate cancer and health-related quality of life: A review of the literature, Psychooncology, 2002.

L. B. Marks, P. R. Carroll, T. C. Dugan, and M. S. Anscher, The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy, Int J Radiat Oncol Biol Phys, vol.31, pp.1257-80, 1995.

S. Haldar, C. Dru, and N. A. Bhowmick, Mechanisms of hemorrhagic cystitis, Am J Clin Exp Urol, vol.2, pp.199-208, 2014.

C. E. Olsson, A. Jackson, J. O. Deasy, and M. Thor, A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Prostate Cancer Radiation Therapy, Int J Radiat Oncol, vol.102, pp.1514-1546, 2018.

L. Budäus, M. Bolla, A. Bossi, C. Cozzarini, J. Crook et al., Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature, Eur Urol, vol.61, pp.112-139, 2012.

M. J. Zelefsky, M. Kollmeier, B. Cox, A. Fidaleo, D. Sperling et al., Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate Cancer, Int J Radiat Oncol, vol.84, pp.125-134, 2012.

W. D. Heemsbergen, A. Al-mamgani, M. G. Witte, M. Van-herk, F. J. Pos et al., Urinary obstruction in prostate cancer patients from the dutch trial (68 Gy vs. 78 Gy): Relationships with local dose, acute effects, and baseline characteristics, Int J Radiat Oncol Biol Phys, vol.78, pp.19-25, 2010.

P. Ghadjar, M. J. Zelefsky, D. E. Spratt, M. Af-rosenschöld, P. Oh et al., Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, vol.88, pp.339-383, 2014.

J. A. Hatton, P. B. Greer, C. Tang, P. Wright, A. Capp et al., Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans, Radiother Oncol, vol.98, pp.162-170, 2011.

F. Palorini, C. Cozzarini, S. Gianolini, A. Botti, V. Carillo et al., First application of a pixel-wise analysis on bladder dose-surface maps in prostate cancer radiotherapy, Radiother Oncol, vol.119, pp.123-131, 2016.

C. Thomas, M. Keyes, M. Liu, and V. Moravan, Segmental Urethral Dosimetry and Urinary Toxicity in Patients With No Urinary Symptoms Before Permanent Prostate Brachytherapy, Int J Radiat Oncol, vol.72, pp.447-55, 2008.

J. J. Earley, A. M. Abdelbaky, M. J. Cunningham, E. Chadwick, S. Langley et al., Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: A matched case-control study, Radiother Oncol, 2012.

G. S. Merrick, W. M. Butler, K. E. Wallner, R. W. Galbreath, R. L. Anderson et al., Risk factors for the development of prostate brachytherapy related urethral strictures, J Urol, pp.681-687, 2006.

A. N. Viswanathan, E. D. Yorke, L. B. Marks, P. J. Eifel, and W. U. Shipley, Radiation Dose-Volume Effects of the Urinary Bladder, Int J Radiat Oncol Biol Phys, vol.76, pp.116-138, 2010.

J. T. Lyman, Complication probability as assessed from dose-volume histograms, Radiat Res, 1985.

G. J. Kutcher, C. Burman, L. Brewster, M. Goitein, and R. Mohan, Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations, Int J Radiat Oncol Biol Phys, pp.90173-90175, 1991.

M. J. Zelefsky, E. J. Levin, M. Hunt, Y. Yamada, A. M. Shippy et al., Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer, Int J Radiat Oncol Biol Phys, vol.70, pp.1124-1133, 2008.

O. Cahlon, M. J. Zelefsky, A. Shippy, H. Chan, Z. Fuks et al., Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes, Int J Radiat Oncol, vol.71, pp.330-337, 2008.

Á. Karlsdóttir, L. P. Muren, T. Wentzel-larsen, and O. Dahl, Late Gastrointestinal Morbidity After Three-Dimensional Conformal Radiation Therapy for Prostate Cancer Fades With Time in Contrast to Genitourinary Morbidity, Int J Radiat Oncol, vol.70, pp.1478-86, 2008.

P. A. Kupelian, T. R. Willoughby, C. A. Reddy, E. A. Klein, and A. Mahadevan, Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience, Int J Radiat Oncol, vol.68, pp.1424-1454, 2007.

A. Al-mamgani, W. D. Heemsbergen, S. Peeters, and J. Lebesque, Role of Intensity-Modulated Radiotherapy in Reducing Toxicity in Dose Escalation for Localized Prostate Cancer, Int J Radiat Oncol Biol Phys, 2009.

M. Thor, C. Olsson, J. H. Oh, S. E. Petersen, D. Alsadius et al., Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy, Radiother Oncol, vol.119, pp.117-139, 2016.

A. Harsolia, C. Vargas, D. Yan, D. Brabbins, D. Lockman et al., Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose-Volume Analysis of a Phase II Dose-Escalation Study, Int J Radiat Oncol Biol Phys, vol.69, pp.1100-1109, 2007.

M. Bakhshandeh, B. Hashemi, S. Mahdavi, A. Nikoofar, M. Vasheghani et al., Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-andneck radiation therapy, Int J Radiat Oncol Biol Phys, 2013.

M. R. Cheung, S. L. Tucker, L. Dong, R. De-crevoisier, A. K. Lee et al., Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, vol.67, pp.1059-65, 2007.

L. B. Marks, E. D. Yorke, A. Jackson, R. K. Ten-haken, L. S. Constine et al., Use of Normal Tissue Complication Probability Models in the Clinic, Int J Radiat Oncol Biol Phys, 2010.

M. Söhn, M. Alber, and D. Yan, Principal Component Analysis-Based Pattern Analysis of Dose-Volume Histograms and Influence on Rectal Toxicity, Int J Radiat Oncol Biol Phys, 2007.

J. A. Dean, K. H. Wong, H. Gay, L. C. Welsh, A. B. Jones et al., Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy, Int J Radiat Oncol Biol Phys, 2016.

S. L. Gulliford, S. Webb, C. G. Rowbottom, D. W. Corne, and D. P. Dearnaley, Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate, Radiother Oncol, 2004.

S. Tomatis, T. Rancati, C. Fiorino, V. Vavassori, G. Fellin et al., Late rectal bleeding after 3D-CRT for prostate cancer: Development of a neural-network-based predictive model, Phys Med Biol, 2012.

A. Pella, R. Cambria, M. Riboldi, B. A. Jereczek-fossa, C. Fodor et al., Use of machine learning methods for prediction of acute toxicity in organs at risk following prostate radiotherapy, Med Phys, 2011.

J. D. Ospina, J. Zhu, C. Chira, A. Bossi, J. B. Delobel et al., Random forests to predict rectal toxicity following prostate cancer radiation therapy, Int. J. Radiat. Oncol. Biol. Phys, 2014.

N. Yahya, M. Ebert, M. Bulsara, M. J. House, A. Kennedy et al., Statistical-learning strategies generate only modestly performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: A comparison of conventional and machine-learning methods, Med Phys, vol.43, pp.2040-52, 2016.

O. Acosta, R. De-crevoisier, and D. Beyond, 2D/3D-Based Dose Comparison to Assess Predictors of Toxicity, Model. Radiother. Side Eff, pp.415-455, 2019.

L. Shelley, J. E. Scaife, M. Romanchikova, K. Harrison, J. R. Forman et al., Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy, Radiother Oncol, vol.123, p.466, 2017.

F. Palorini, A. Botti, V. Carillo, S. Gianolini, I. Improta et al., Bladder dose-surface maps and urinary toxicity: Robustness with respect to motion in assessing local dose effects, Phys Medica, vol.32, pp.506-517, 2016.

M. H. Stenmark, A. Conlon, S. Johnson, S. Daignault, D. Litzenberg et al., Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer, Radiother Oncol, 2014.

M. A. Ebert, K. Foo, A. Haworth, S. L. Gulliford, A. Kennedy et al., Gastrointestinal dosehistogram effects in the context of dose-volume-constrained prostate radiation therapy: Analysis of data from the radar prostate radiation therapy trial, Int J Radiat Oncol Biol Phys, 2015.

S. Peeters, J. V. Lebesque, W. D. Heemsbergen, W. Van-putten, A. Slot et al., Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, 2006.

W. D. Heemsbergen, M. S. Hoogeman, G. Hart, J. V. Lebesque, and P. Koper, Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy, Int J Radiat Oncol Biol Phys, 2005.

M. S. Hoogeman, M. Van-herk, D. Bois, J. Muller-timmermans, P. Koper et al., Quantification of local rectal wall displacements by virtual rectum unfolding, Radiother Oncol, 2004.

M. G. Witte, W. D. Heemsbergen, R. Bohoslavsky, F. J. Pos, A. Al-mamgani et al., Relating Dose Outside the Prostate With Freedom From Failure in the Dutch Trial 68 Gy vs. 78 Gy, Int J Radiat Oncol Biol Phys, 2010.

O. Acosta, G. Drean, J. D. Ospina, A. Simon, P. Haigron et al., Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy, Phys Med Biol, vol.58, pp.2581-95, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00805142

G. Dréan, O. Acosta, J. D. Ospina, A. Fargeas, C. Lafond et al., Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT, Radiother Oncol, vol.119, pp.388-97, 2016.

S. Monti, G. Palma, D. 'avino, V. Gerardi, M. Marvaso et al., Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients, Sci Rep, vol.7, p.7220, 2017.

A. Mcwilliam, J. Kennedy, C. Hodgson, V. Osorio, E. Faivre-finn et al., Radiation dose to heart base linked with poorer survival in lung cancer patients, Eur J Cancer, vol.85, pp.106-119, 2017.

C. Lafond, N. 'guessan, J. Dréan, G. Perichon, N. Delaby et al., PO-0841: Feasibility of dose decrease in a rectal subregion predictive of bleeding in prostate radiotherapy, Radiother Oncol, vol.123, issue.17, pp.31278-31279, 2017.

R. Munbodh, A. Jackson, J. Bauer, C. R. Schmidtlein, and M. J. Zelefsky, Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer, Med Phys, vol.35, pp.2137-50, 2008.

S. L. Tucker, M. Zhang, L. Dong, R. Mohan, D. Kuban et al., Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: A case-control study, Int J Radiat Oncol Biol Phys, vol.64, pp.1255-64, 2006.

F. Buettner, S. L. Gulliford, S. Webb, and M. Partridge, Using dose-surface maps to predict radiationinduced rectal bleeding: a neural network approach, Phys Med Biol, vol.54, pp.5139-53, 2009.

F. Buettner, S. L. Gulliford, S. Webb, and M. Partridge, Modeling late rectal toxicities based on a parameterized representation of the 3D dose distribution, Phys Med Biol, vol.56, pp.2103-2121, 2011.

F. Buettner, S. L. Gulliford, S. Webb, M. R. Sydes, D. P. Dearnaley et al., The dose-response of the anal sphincter region -An analysis of data from the MRC RT01 trial, Radiother Oncol, 2012.

C. R. Moulton, M. J. House, V. Lye, C. I. Tang, M. Krawiec et al., Spatial features of dosesurface maps from deformably-registered plans correlate with late gastrointestinal complications, Phys Med Biol, 2017.

R. C. Wortel, M. G. Witte, U. A. Van-der-heide, F. J. Pos, J. V. Lebesque et al., Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer, Radiother Oncol, vol.117, pp.515-535, 2015.

I. Improta, F. Palorini, C. Cozzarini, T. Rancati, B. Avuzzi et al., Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer, Phys Medica, vol.32, pp.1681-1690, 2016.

N. Yahya, M. A. Ebert, M. J. House, A. Kennedy, J. Matthews et al., Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder Surface, Int J Radiat Oncol, vol.97, pp.420-426, 2017.

X. Zhen, J. Chen, Z. Zhong, B. Hrycushko, L. Zhou et al., Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: A feasibility study, Phys Med Biol, 2017.

S. Monti, R. Pacelli, L. Cella, and G. Palma, Inter-patient image registration algorithms to disentangle regional dose bioeffects, Sci Rep, vol.8, p.4915, 2018.

G. Dréan, O. Acosta, C. Lafond, A. Simon, R. De-crevoisier et al., Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy, Med Phys, vol.43, pp.2721-2751, 2016.

J. Ashburner and K. J. Friston, Voxel-Based Morphometry-The Methods, Neuroimage, vol.11, pp.805-826, 2000.

G. Palma, S. Monti, V. D. Avino, M. Conson, R. Liuzzi et al., A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung Damage, Radiat Oncol Biol, vol.96, pp.127-160, 2016.

O. Acosta, D. Crevoisier, R. Beyond, and D. ,

P. Castadot, J. A. Lee, A. Parraga, X. Geets, B. Macq et al., Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors, Radiother Oncol, 2008.

F. J. Salguero, N. K. Saleh-sayah, C. Yan, and J. Siebers, Estimation of three-dimensional intrinsic dosimetric uncertainties resulting from using deformable image registration for dose mapping, Med Phys, 2011.

T. Rohlfing, Image similarity and tissue overlaps as surrogates for image registration accuracy: Widely used but unreliable, IEEE Trans Med Imaging, 2012.

C. Fiorino and F. Palorini, SP-0215: Advanced methods for 2D/3D dose map correlation in modelling toxicity, Radiother Oncol, vol.115, pp.108-117, 2015.

J. R. Chumbley and K. J. Friston, False discovery rate revisited: FDR and topological inference using Gaussian random fields, Neuroimage, vol.44, pp.62-70, 2009.

. Smith-s and . Nichols-t, Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference, Neuroimage, vol.44, pp.83-98, 2009.

C. Chen, M. Witte, W. Heemsbergen, and M. Van-herk, Multiple comparisons permutation test for image based data mining in radiotherapy, Radiat Oncol, vol.8, p.293, 2013.

A. Mcwilliam, C. Faivre-finn, J. Kennedy, L. Kershaw, and M. B. Van-herk, Data Mining Identifies the Base of the Heart as a Dose-Sensitive Region Affecting Survival in Lung Cancer Patients, Int J Radiat Oncol, 2016.

A. P. Holmes, R. C. Blair, J. Watson, and I. Ford, Nonparametric Analysis of Statistic Images from Functional Mapping Experiments, J Cereb Blood Flow Metab, vol.16, pp.7-22, 1996.

A. W. Pederson, J. Fricano, D. Correa, C. A. Pelizzari, and S. L. Liauw, Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: An exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity, Int J Radiat Oncol Biol Phys, vol.82, pp.235-276, 2012.

F. Palorini, T. Rancati, C. Cozzarini, I. Improta, V. Carillo et al., Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy, Radiother Oncol, vol.118, pp.92-100, 2016.

L. J. Boersma, M. Van-den-brink, A. M. Bruce, T. Shouman, L. Gras et al., Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms, Int J Radiat Oncol Biol Phys, vol.41, pp.37-43, 1998.

M. R. Storey, A. Pollack, G. Zagars, L. Smith, J. Antolak et al., Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial, Int J Radiat Oncol, vol.48, pp.700-708, 2000.

T. Rosewall, C. Catton, G. Currie, A. Bayley, P. Chung et al., The relationship between external beam radiotherapy dose and chronic urinary dysfunction -A methodological critique, Radiother Oncol, vol.97, pp.40-47, 2010.

M. Nassef, A. Simon, G. Cazoulat, A. Duménil, C. Blay et al., Quantification of dose uncertainties in cumulated dose estimation compared to planned dose in prostate IMRT, Radiother Oncol, vol.119, pp.129-165, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01301536

D. Pearson, S. K. Gill, N. Campbell, and K. Reddy, Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation, J Appl Clin Med Phys, vol.17, pp.107-124, 2016.

S. De-langhe, D. Meerleer, G. , D. Ruyck, K. Ost et al., Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: Making informed decisions, Radiother Oncol, vol.112, pp.95-104, 2014.

G. C. Barnett, D. Meerleer, G. Gulliford, S. L. Sydes, M. R. Elliott et al., The Impact of Clinical Factors on the Development of Late Radiation Toxicity: Results from the Medical Research Council RT01 Trial (ISRCTN47772397), Clin Oncol, vol.23, pp.613-637, 2011.

C. Cozzarini, T. Rancati, V. Carillo, F. Civardi, E. Garibaldi et al., Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Ad interim results of a cohort study, Eur Urol, vol.13, pp.114-119, 2014.

A. A. Ahmed, B. Egleston, P. Alcantara, L. Li, A. Pollack et al., A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints, Int J Radiat Oncol Biol Phys, vol.86, pp.709-724, 2013.

R. Mathieu, J. Arango, V. Beckendorf, J. B. Delobel, T. Messai et al., Nomograms to predict late urinary toxicity after prostate cancer radiotherapy, World J Urol, vol.32, pp.743-51, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00911324

N. Yahya, M. A. Ebert, M. Bulsara, A. Haworth, A. Kennedy et al., Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial, Radiother Oncol, vol.116, pp.112-120, 2015.

G. C. Barnett, C. E. Coles, R. M. Elliott, C. Baynes, C. Luccarini et al., Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study, Lancet Oncol, vol.13, issue.11, pp.70302-70305, 2012.

J. J. Smith, I. Wasserman, S. A. Milgrom, O. S. Chow, C. Chen et al., Single Nucleotide Polymorphism TGF?1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients, Int J Radiat Oncol Biol Phys, vol.97, pp.924-954, 2017.

M. Someya, M. Hori, T. Gocho, K. Nakata, T. Tsuchiya et al., Prediction of acute gastrointestinal and genitourinary radiation toxicity in prostate cancer patients using lymphocyte microRNA, Jpn J Clin Oncol, vol.48, pp.167-74, 2018.

J. Bucci, I. Spadinger, M. Hilts, S. Sidhu, C. Smith et al., Urethral and periurethral dosimetry in prostate brachytherapy: Is there a convenient surrogate, Int J Radiat Oncol Biol Phys, 2002.

F. M. Waterman and A. P. Dicker, Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan, Med Phys, 2000.

O. Commowick, V. Grégoire, and G. Malandain, Atlas-based delineation of lymph node levels in head and neck computed tomography images, Radiother Oncol, 2008.
URL : https://hal.archives-ouvertes.fr/inria-00616080

S. Martin, V. Daanen, and J. Troccaz, Atlas-based prostate segmentation using an hybrid registration, Int J Comput Assist Radiol Surg, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00289854

P. Aljabar, R. A. Heckemann, A. Hammers, J. V. Hajnal, and D. Rueckert, Multi-atlas based segmentation of brain images: Atlas selection and its effect on accuracy, Neuroimage, 2009.

T. R. Langerak, U. A. Van-der-heide, A. Kotte, M. A. Viergever, M. Van-vulpen et al., Label fusion in atlas-based segmentation using a selective and iterative method for performance level estimation (SIMPLE), IEEE Trans Med Imaging, 2010.

?. Martin, J. Troccaz, and V. Daanen, Automated segmentation of the prostate in 3D MR images using a probabilistic atlas and a spatially constrained deformable model, Med Phys, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00456598

L. Ramus, J. Thariat, P. Marcy, Y. Pointreau, G. Bera et al., Automatic segmentation using atlases in head and neck cancers: Methodology. Cancer/Radiotherapie, 2010.

E. M. Van-rikxoort, M. Prokop, D. Hoop, B. Viergever, M. A. Pluim et al., Automatic segmentation of pulmonary lobes robust against incomplete fissures, IEEE Trans Med Imaging, 2010.

T. Rohlfing, R. Brandt, R. Menzel, and C. R. Maurer, Evaluation of atlas selection strategies for atlas-based image segmentation with application to confocal microscopy images of bee brains, Neuroimage, 2004.

O. Acosta, J. Dowling, G. Drean, A. Simon, D. Crevoisier et al., Multi-atlas-based segmentation of pelvic structures from ct scans for planning in prostate cancer radiotherapy
URL : https://hal.archives-ouvertes.fr/inserm-00910761

A. Thorac, Imaging An Eng. Clin. Perspect, 2014.

S. K. Warfield, K. H. Zou, and W. M. Wells, Simultaneous truth and performance level estimation (STAPLE): An algorithm for the validation of image segmentation, IEEE Trans Med Imaging, 2004.

M. Mccormick, X. Liu, J. Jomier, C. Marion, and L. Ibanez, Itk: Enabling reproducible research and open science. Front Neuroinform, 2014.

O. Acosta, A. Simon, F. Monge, F. Commandeur, C. Bassirou et al., Evaluation of multiatlas-based segmentation of CT scans in prostate cancer radiotherapy, Proc. -Int. Symp. Biomed. Imaging, 2011.

I. I?gum, M. Staring, A. Rutten, M. Prokop, M. A. Viergever et al., Multi-atlas-based segmentation with local decision fusion-application to cardiac and aortic segmentation in CT scans, IEEE Trans Med Imaging, 2009.

V. Beckendorf, S. Guerif, L. Prisé, E. Cosset, J. Bougnoux et al., 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial, Int J Radiat Oncol, vol.80, pp.1056-63, 2011.

P. T. Kataria, M. Medicity, and M. Medicity, Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: An MRI based approach, 2016.

H. K. Lee, D. Souza, W. D. Yamal, J. Pollack, A. Lee et al., Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer, Int J Radiat Oncol Biol Phys, 2003.

I. Improta, F. Palorini, C. Cozzarini, T. Rancati, B. Avuzzi et al., Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer, Phys Medica, 2016.

R. De-crevoisier, M. A. Bayar, P. Pommier, X. Muracciole, F. Pêne et al., Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial, Int J Radiat Oncol, vol.102, pp.1420-1429, 2018.

C. N. Catton, H. Lukka, C. Gu, J. M. Martin, S. Supiot et al., Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer, J Clin Oncol, vol.35, pp.1884-90, 2017.

L. E. Chambless and G. Diao, Estimation of time-dependent area under the ROC curve for long-term risk prediction, Stat Med, vol.25, pp.3474-86, 2006.

R. Tibshirani, Regression Shrinkage and Selection via the Lasso, J R Stat Soc Ser B, vol.58, pp.267-88, 1996.

R. Tibshirani, The lasso method for variable selection in the Cox model, Stat Med, vol.16, pp.385-95, 1997.

J. Friedman, T. Hastie, and R. Tibshirani, Regularization Paths for Generalized Linear Models via Coordinate Descent, J Stat Softw, vol.33, pp.1-22, 2010.

T. Hastie, R. Tibshirani, and J. Friedman, The elements of statistical learning: data mining, inference, and prediction

O. Acosta, E. Mylona, L. Dain, M. Voisin, C. Lizee et al., Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy, Radiother Oncol, vol.125, pp.492-501, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01671693

S. Klein, M. Staring, K. Murphy, M. A. Viergever, and P. J. Elastix, A Toolbox for Intensity-Based Medical Image Registration, IEEE Trans Med Imaging, vol.29, pp.196-205, 2010.

M. Dubuisson and A. K. Jain, A modified Hausdorff distance for object matching, Proc. 12th Int. Conf. Pattern Recognit, vol.1, pp.566-574

N. Yahya, M. A. Ebert, M. Bulsara, M. J. House, A. Kennedy et al., Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multipleevent and event-count models, Radiother Oncol, vol.117, pp.277-82, 2015.

V. W. Nitti, The prevalence of urinary incontinence, Rev Urol, vol.3, issue.1, pp.2-6, 2001.

J. Delobel, K. Gnep, J. D. Ospina, V. Beckendorf, C. Chira et al., Nomogram to predict rectal toxicity following prostate cancer radiotherapy, PLoS One, vol.12, p.179845, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01560367

J. W. Denham, A. Steigler, D. Joseph, D. S. Lamb, N. A. Spry et al., Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial, Radiother Oncol, 2015.

N. Yahya, M. A. Ebert, M. Bulsara, A. Kennedy, D. J. Joseph et al., Independent external validation of predictive models for urinary dysfunction following external beam radiotherapy of the prostate: Issues in model development and reporting, Radiother Oncol, vol.120, pp.339-384, 2016.

J. W. Denham, C. Wilcox, D. Joseph, N. A. Spry, D. S. Lamb et al., Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): Secondary endpoints from a randomised phase 3 factorial trial, Lancet Oncol, 2012.

A. Haworth, R. Kearvell, P. B. Greer, B. Hooton, J. W. Denham et al., Assuring high quality treatment delivery in clinical trials -Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study, Radiother Oncol, 2009.

M. A. Ebert, A. Haworth, R. Kearvell, B. Hooton, R. Coleman et al., Detailed review and analysis of complex radiotherapy clinical trial planning data: Evaluation and initial experience with the SWAN software system, Radiother Oncol, 2008.

J. W. Denham, C. Wilcox, D. S. Lamb, N. A. Spry, G. Duchesne et al., Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer, Radiother Oncol, 2012.

M. A. Ebert, M. Bulsara, A. Haworth, R. Kearvell, S. Richardson et al., Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: Are the results reflected in observed toxicity rates, J Med Imaging Radiat Oncol, 2015.

R. Kearvell, A. Haworth, M. A. Ebert, J. Murray, B. Hooton et al., Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 "RADAR" trial, J Med Imaging Radiat Oncol, 2013.

J. W. Denham, D. Joseph, D. S. Lamb, N. A. Spry, G. Duchesne et al., Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, Lancet Oncol, vol.3, issue.18, pp.30757-30762, 2019.

J. W. Denham, M. Nowitz, D. Joseph, G. Duchesne, N. A. Spry et al., Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced pr, BJU Int, 2014.

M. A. Ebert, A. Haworth, R. Kearvell, B. Hooton, B. Hug et al., Comparison of DVH data from multiple radiotherapy treatment planning systems, Phys Med Biol, 2010.

B. Krawczyk, Learning from imbalanced data: open challenges and future directions, Prog Artif Intell, vol.5, pp.221-253, 2016.

J. Friedman, T. Hastie, and R. Tibshirani, Additive logistic regression: a statistical view of boosting (With discussion and a rejoinder by the authors), Ann Stat, vol.28, pp.337-407, 2000.

B. Efron, Bayes' Theorem in the 21st Century, Science (80-), vol.340, pp.1177-1185, 2013.

G. J. Pang-s and . C5, 0 Classification Algorithm and Application on Individual Credit Evaluation of Banks, vol.29, pp.94-104, 2009.

M. Fordellone, A. Bellincontro, and F. Mencarelli, Partial least squares discriminant analysis: A dimensionality reduction method to classify hyperspectral data, 2018.

J. H. Friedman, Regularized Discriminant Analysis, J Am Stat Assoc, vol.84, p.165, 1989.

N. V. Chawla, K. W. Bowyer, L. O. Hall, and W. P. Kegelmeyer, SMOTE: Synthetic minority over-sampling technique, J Artif Intell Res, 2002.

H. Han, W. Wang, and B. Mao, Borderline-SMOTE: A New Over-Sampling Method in Imbalanced Data Sets Learning, pp.878-87, 2005.

G. Batista, R. C. Prati, and M. C. Monard, A study of the behavior of several methods for balancing machine learning training data, ACM SIGKDD Explor Newsl, vol.6, p.20, 2004.

D. L. Wilson, Asymptotic Properties of Nearest Neighbor Rules Using Edited Data, IEEE Trans Syst Man Cybern, 1972.

H. He, Y. Bai, E. A. Garcia, and S. Li, ADASYN: Adaptive synthetic sampling approach for imbalanced learning, IEEE Int. Jt. Conf. Neural Networks, pp.1322-1330, 2008.

G. Dumancas and G. Bello, Comparison of Machine-Learning Techniques for Handling Multicollinearity in Big Data Analytics and High Performance Data Mining, 2015.

V. López, A. Fernández, S. García, V. Palade, and F. Herrera, An insight into classification with imbalanced data: Empirical results and current trends on using data intrinsic characteristics, Inf Sci (Ny), vol.250, pp.113-154, 2013.

A. More, Survey of resampling techniques for improving classification performance in unbalanced datasets, 2016.

A. D. Pozzolo, O. Caelen, and G. Bontempi, When is undersampling effective in unbalanced classification tasks?, Lect. Notes Comput. Sci. (including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics), 2015.

C. Ferri, J. Hernández-orallo, and R. Modroiu, An experimental comparison of performance measures for classification, Pattern Recognit Lett, 2009.

C. X. Ling, J. Huang, and H. Zhang, AUC: A statistically consistent and more discriminating measure than accuracy, IJCAI Int. Jt. Conf. Artif. Intell, 2003.

D. J. Hand, Measuring classifier performance: A coherent alternative to the area under the ROC curve, Mach Learn, 2009.

J. Jung, H. K. Ahn, and Y. Huh, Clinical and functional anatomy of the urethral sphincter, Int Neurourol J, vol.16, pp.102-108, 2012.

E. Basch, X. Jia, G. Heller, A. Barz, L. Sit et al., Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes, J Natl Cancer Inst, 2009.

E. Basch, A. Iasonos, T. Mcdonough, A. Barz, A. Culkin et al., Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study, Lancet Oncol, issue.06, p.70910, 2006.

H. G. Van-der-poel, C. Tillier, D. Blok, W. M. Acar, C. Van-muilekom et al., Interview-based versus questionnaire-based quality of life outcomes before and after prostatectomy, J Endourol, 2013.

D. Maio, M. Gallo, C. Leighl, N. B. Piccirillo, M. C. et al., Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials, J Clin Oncol, 2015.

E. S. Andersen, L. P. Muren, T. S. Sørensen, K. Noe, M. Thor et al., Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer, Phys Med Biol, 2012.

M. Thor, L. Bentzen, L. B. Hysing, C. Ekanger, S. I. Helle et al., Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions, Radiother Oncol, vol.107, pp.147-52, 2013.

S. Lee, S. Kerns, H. Ostrer, B. Rosenstein, J. O. Deasy et al., Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy, Int J Radiat Oncol Biol Phys, vol.101, pp.128-163, 2018.

S. L. Kerns, L. Dorling, L. Fachal, S. Bentzen, P. Pharoah et al., Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer, EBioMedicine, vol.10, pp.150-63, 2016.

R. Rios, D. Crevoisier, R. Ospina, J. D. Commandeur, F. Lafond et al., Population model of bladder motion and deformation based on dominant eigenmodes and mixed-effects models in prostate cancer radiotherapy, Med Image Anal, vol.38, pp.133-182, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01518411

R. Rios, J. D. Ospina, C. Lafond, O. Acosta, J. Espinosa et al., Characterization of Bladder Motion and Deformation in Prostate Cancer Radiotherapy. IRBM, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01484707